Production (Stage)
Firefly Neuroscience, Inc.
AIFF
$3.46
$0.102.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,052.41% | -251.44% | -559.85% | -284.19% | -105.12% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18,866.10% | 1,592.65% | 3,096.20% | -21.62% | -20.27% |
| Change in Net Operating Assets | -208.59% | 171.94% | -389.68% | 122.99% | -206.67% |
| Cash from Operations | -90.37% | -138.82% | -246.97% | -56.33% | -466.09% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 101.04% | -- | -- | -- |
| Cash from Investing | 94.66% | 80.31% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -80.84% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 50.79% | -- | -100.00% | -100.00% | 521.71% |
| Repurchase of Preferred Stock | -- | 60.03% | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 984.97% | -12.67% | 173.58% | -100.00% | 242.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,631.68% | -53.60% | 59.71% | -620.33% | -1,274.42% |